Evidence map›Paper›PMID 20143087›Full record

ArticleMedical microbiology and immunology2010

Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization.

A Errea, G Moreno, F Sisti, J Fernández, M Rumbo, Daniela Flavia Hozbor

Abstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A ErreaFacultad de Ciencias Exactas, Laboratorio de Investigaciones del Sistema Inmune (LISIN), UNLP 47 y 115, 1900, La Plata, Argentina.
G Moreno
F Sisti
J Fernández
M Rumbo
Daniela Flavia Hozbor

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-specific enhancement of the airways innate response has been shown to impair lung infections in several models of infection such diverse as influenza A, Streptococcus pneumoniae, and Aspergillus niger. Our aim was to evaluate whether a similar event could operate in the context of Bordetella pertussis respiratory infection, not only to enrich the knowledge of host-bacteria interaction but also to establish immunological basis for the development of new control strategies against the pathogen. Using a B. pertussis intranasal infection model and coadministration of different TLR agonists at the moment of the infection, we observed that the enhancement of innate response activation, in a TLR4-dependent way, could efficiently impair B. pertussis colonization (P < 0.001). While LPS from different microbial sources were equally effective in promoting this effect, flagellin and poly I:C coadministration, in spite of inducing expression of innate response markers TNFalpha, CXCL2, CXCL10 and IL6, was not effective to prevent B. pertussis colonization. Our results indicate that during the early stage of infection, specific anti-microbial mechanisms triggered by TLR4 stimulation are able to impair B. pertussis colonization. These findings could complement our current view of the role of TLR4-dependent processes that contribute to anti-pertussis immunity.

Indexed as

Immunity, MucosalAnimalsBordetella pertussisChemokine CXCL10Chemokine CXCL2FemaleImmunity, InnateInterleukin-6LipopolysaccharidesLungMiceMice, Inbred BALB CMice, Inbred C3HToll-Like Receptor 4Tumor Necrosis Factor-alphaWhooping CoughChemokine CXCL10Chemokine CXCL2Cxcl10 protein, mouseCxcl2 protein, mouseInterleukin-6LipopolysaccharidesTlr4 protein, mouseToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.